RSS
|
Login
|
Register
HOME
SPECIALTY
Cardiologists
Endocrinologists
Hematology-Oncology
Infectious Disease
Long Term Care
Nurses
Nurse Practitioners
OB/GYN
Pain Specialists
Pediatricians
Pharmacists
Physician Assistants
Primary Care Physicians
Residents
Rheumatologists
Urologists
RESOURCE CENTERS
Allergic Disorders
Cardiovascular System
Central Nervous System
Dental
Dermatological Disorders
Diagnostic Agents
Ear Disorders
Endocrine System
Eye Disorders
Gastrointestinal Tract
Hematology
Immune System
Infections & Infestations
Metabolic Disorders
Musculoskeletal Disorders
Nutrition
OB/GYN
Oncology
Pain & Pyrexia
Poisoning & Drug Dependence
Respiratory Tract
Urogenital System
DRUG INTERACTIONS
NEWS
Conference Coverage
Drug News
Drug Safety Alerts and Recalls
Drugs in the Pipeline
New Drug Products
FDA Drug Shortages
Features
Newsletters
News from Haymarket Journals
Polls
CLINICAL CHARTS
Clinical Charts
Chemotherapy Regimens
TOOLS
Drug Interactions Checker
Calculators
Industry Supported Education
Pharmacology Notes
Patient Information
Common Medical Abbreviations
Drug Monograph Format
FDA Orange Book
Professional Associations
Contests
DOWNLOAD
SUBSCRIBE
Customer Service
MPR Publications
Subscription Info (Physician/Residents)
Subscription Info (Nurse Practitioners)
Subscription Info (Physician Assistants)
CME
BRAND NAME
GENERIC NAME
DISEASE
MANUFACTURERS
COMPARE DRUGS
JOBS
New Product of the Week
OXECTA
2/6/2012
Pfizer Labs
Pharmacological Class:
Opioid.
Active Ingredient(s):
Oxycodone HCl 5mg, 7.5mg; tabs.
Indication:
For the management of acute and chronic moderate to severe pain where the use of an opioid analgesic is appropriate.
more »
Drug News, Safety Alerts & Recalls
RA Drug Trial Funding Source Not Linked to Outcome
Increased ADHD Rates in Children Exposed to Anesthesia
Stroke Victims Not Getting to Hospital Any Faster
Janumet XR Approved for Type 2 Diabetes
Direct to Consumer Statin Web Sites of Poor Quality
more »
Drugs in the Pipeline
Phase 2 Trial of OGX-427 for Metastatic Castrate-Resistant Prostate Cancer
Phase 2 Trial of Captisol-Enabled, Propylene Glycol-Free Melphalan for Multiple Myeloma Patients Undergoing Autologous Transplantation
Phase 3 Trial Update of Lubiprostone for Opioid-Induced Bowel Dysfunction (OBD)
Phase 2 Trial of AGS-003 with Sunitinib for Advanced Renal Cell Carcinoma
NDA Accepted for Gattex for Adult Short Bowel Syndrome
more »
Featured Chart of the Week
Neuropathic Pain Treatments
Medications used to treat neuropathic pain, including diabetic peripheral neuropathy, fibromyalgia, and postherpetic neuralgia.
more »
Stay Connected
Follow us on Twitter
Join us on Facebook
Updated Drugs
OPTIRAY 240
Diagnostic Agents > Diagnostic agents
Monograph added.
Updated:
2/7/2012
OPTIRAY 300
Diagnostic Agents > Diagnostic agents
Monograph added.
Updated:
2/7/2012
OPTIRAY 320
Diagnostic Agents > Diagnostic agents
Monograph added.
Updated:
2/7/2012
OPTIRAY 350
Diagnostic Agents > Diagnostic agents
Monograph added.
Updated:
2/7/2012
more »
Subscribe to the RSS for this page [
view all our RSS feeds here
]
Most Popular
Most Emailed
Most Recent
RECALL: Lo/Ovral-28 Recalled Due to Packaging Error
Jentadueto Approved for Type 2 Diabetes
Janumet XR Approved for Type 2 Diabetes
Diabetes Drugs Affect Pancreatic Cancer Risk
AAP: Childhood Vaccination Schedules Approved for 2012
Proton Pump Inhibitor Use Ups Hip Fracture Risk for Women
Apixaban Beats Aspirin for Stroke Prevention in A-Fib
Kalydeco Approved to Treat Underlying Cause of Cystic Fibrosis
Rivaroxaban Tied to Lower Brain Bleed Risk in A-Fib
Gleevec Treatment of Duration for GIST Extended
Neuropathic Pain Treatments
Migraine and Headache Treatments
Antiretroviral Treatment Chart
SAFETY ALERT: Packaging Errors for Opiate Products from Endo by Novartis Consumer Health
Arthritis Treatments: NSAIDS
RECALL: Lo/Ovral-28 Recalled Due to Packaging Error
Antiretroviral Contraindications and Drug Interactions Chart
Bydureon Approved for Once-Weekly Treatment of Type 2 Diabetes
Statins Increase Diabetes Risk for Postmenopausal Women
SSRIs Increase Fall Risk in Elderly Dementia Patients
DRAGON Score Helps Predict Functional Outcomes in Stroke
Many Self-Harming Youth Get Inadequate Mental Health Care
New Assay IDs Individuals With Major Depressive Disorder
Change in Fitness or Fatness Impacts Cardio Risk Factors
Startle Response Up in Early-Onset Alcohol Dependence
Weight Loss Impacts Leg Muscle, Strength in Knee OA
RA Drug Trial Funding Source Not Linked to Outcome
Same Gene Variants in Early- and Late-Onset Alzheimer's
Alanine Aminotransferase Levels ID Liver Disease Risk
Personalized Liver Cells Support Hepatitis C Virus
ClinicalJobAdvisor
Loading...
More Jobs
Please register or log-in now.
By logging into our site, you help our editors to learn which articles and Web site sections you and your colleagues find most useful. This will help us make eMPR.com more relevant.
Log-in here